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Clinical findings
A 5-year-old boy presented with a history of dry scaly
skin. He had been born at term, with no collodion
membrane or erythroderma noted at delivery. Skin
changes were noted soon after birth, with widespread
dryness and occasional blistering, mainly affecting the
toes. Previous treatment with emollients and topical
corticosteroids had not resulted in improvement. There
was no family history of dermatological disease, and
his parents were not related. Physical examination
revealed mild, light-grey hyperkeratosis, particularly
on the extensor aspects of the skin overlying the joints
and the dorsal surfaces of the feet. In addition, superfi-
cially denuded areas with collarette-like borders
(known as the Mauserung phenomenon) were seen,
most notably on the knees (Fig. 1a–c). The palms,
soles, head and neck were spared, and the hair and all
nails were normal.
Histopathological findings
Histological examination of a skin biopsy taken from
the ankle region showed marked hyperkeratosis of the
stratum corneum and a prominent granular layer
with vacuolization (Fig. 2a).
What is your diagnosis?
(a)
(b) (c)
Figure 1 (a) Light-grey hyperkeratosis overlying the ankle and
the dorsa of the feet; (b) superficially denuded area with col-
larette border on the skin overlying the knee (known as the
Mauserung phenomenon, or moulting), which develops due to
superficial blistering and shedding of the stratum corneum; (c)
hyperkeratosis of the ankle, with well-defined peeling skin, con-
sistent with the Mauserung phenomenon, i.e. small patches of
apparently normal skin in the middle of areas of hyperkeratosis.
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Diagnosis
Superficial epidermolytic ichthyosis (SEI) (formerly
known as ichthyosis bullosa of Siemens1).
Discussion
Ichthyosis as a general term describes skin changes
characterized by hyperkeratosis and/or scaling. The
nomenclature of the inherited ichthyoses has been
revised recently.1 Disorders caused by keratin muta-
tions come under the umbrella term of keratinopathic
ichthyoses. Epidermolytic ichthyosis (EI) (formerly
known as bullous ichthyosis, bullous congenital
ichthyosiform erythroderma, epidermolytic hyperker-
atosis or ichthyosis exfoliativa) and SEI are both
included within this group.
SEI is an autosomal dominant disorder affecting the
keratin (K)2 filament. It was first described by Siemens
in 1937, when it was recognized as distinct from the
more severe EI, which affects both K1 and K10 fila-
ments. Specific keratins are expressed in different cells
of the epidermis; K1 and K10 are expressed in the
suprabasal layer, whereas K2 is expressed later in dif-
ferentiation, in the upper spinous and granular lay-
ers.2 This expression pattern accounts for the milder
phenotype seen in SEI. Unlike EI, SEI does not tend to
present with erythroderma at birth, and the skin
changes of hyperkeratosis and scaling are often more
subtle, commonly affecting the extensor surfaces
around joints. However, these disorders can overlap
clinically and are then difficult to distinguish by skin
changes alone, making DNA sequencing an important
diagnostic tool.
Mutations in KRT2 cause SEI, and since this was
elucidated in 1994,3 15 disease-causing mutations
have been reported. A review of the literature revealed
no obvious relationship between the mutation and the
resulting clinical phenotype in terms of severity, distri-
bution or distinctive features of the condition.
Keratins are intermediate filament proteins. Pairs of
type I (acidic) and type II (basic) keratins coil together
to form heterodimers, which provide structural integ-
rity to the keratinocytes within the epidermis. Causa-
tive mutations in SEI mainly affect the highly
conserved 2B helix of the K2 protein, and less com-
monly the 1A helix, both functionally important for
the formation of a heterodimer with its partner
keratin.
The findings of hyperkeratosis and blistering in our
patient pointed towards a keratinopathic ichthyosis.
The distinctive focal skin peeling, together with the
mild phenotype and epidermolysis close to the stratum
corneum raised the suspicion of SEI. To confirm this
clinical diagnosis, sequencing of the KRT2 gene was
performed, which revealed a heterozygous G to A tran-
sition in codon 494 (c.1462G>A, p.E494K; reference
sequence: NM_000423.2), which has been reported
once previously4 and is known to be a pathogenic
mutation (Fig. 2b). The substitution of lysine for glu-
tamic acid in the K2 protein interferes with heterodi-
mer formation. Subsequent testing of our patient’s
parents revealed that the mutation had occurred de
novo.
Treatment for SEI is aimed at symptom relief. Topi-
cal therapy with keratolytics and emollients is useful
for the hyperkeratosis. Retinoids can also be used,
either topically for milder symptoms or orally for more
severe cases. The blistering seen in SEI improves with
age.
(a)
(b)
Figure 2 (a) Marked hyperkeratosis and a prominent granular
layer, with (inset) scattered vacuolization. Haematoxylin and
eosin, original magnification (a) 9 20; (inset) 9 40. (b) Recur-
rent, sporadic mutation in the KRT2 gene (c.1462G>A, p.E494K;
reference sequence: NM_000423.2) demonstrated in the genomic
DNA of the affected patient (red arrow), which was not present
in the genomic DNA of either parent.
Clinicopathological case
Clinical and Experimental Dermatology (2016) 41, pp828–830 829ª 2016 The Authors. Clinical and Experimental Dermatology published by
John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
CPD
Learning points
• SEI is a rare autosomal dominant genoder-
matosis that can be inherited or occur on a spo-
radic basis.
• Key features include hyperkeratosis, blistering
and localized superficial skin peeling. Blistering
improves with age.
• Histologically, epidermolysis is seen in the
granular layer.
• Genetic testing for a mutation in KRT2 can be
useful in confirming the diagnosis.
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